Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer von Tutt, Andrew N.J, Garber, Judy E, Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D, de Azambuja, Evandro, Fielding, Anitra, Balmaña, Judith, Domchek, Susan M, Gelmon, Karen A, Hollingsworth, Simon J, Korde, Larissa A, Linderholm, Barbro, Bandos, Hanna, Senkus, Elżbieta, Suga, Jennifer M, Shao, Zhimin, Pippas, Andrew W, Nowecki, Zbigniew, Huzarski, Tomasz, Ganz, Patricia A, Lucas, Peter C, Baker, Nigel, Loibl, Sibylle, McConnell, Robin, Piccart, Martine, Schmutzler, Rita, Steger, Guenther G, Costantino, Joseph P, Arahmani, Amal, Wolmark, Norman, McFadden, Eleanor, Karantza, Vassiliki, Lakhani, Sunil R, Yothers, Greg, Campbell, Christine, Geyer, Charles E

Volltext

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatme... von Pivot, X., Bondarenko, I., Nowecki, Z., Dvorkin, M., Trishkina, E., Ahn, J.-H., Im, S.-A., Sarosiek, T., Chatterjee, S., Wojtukiewicz, M.Z., Shparyk, Y., Moiseyenko, V., Bello, M., Semiglazov, V., Lee, Y., Lim, J.

Volltext

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes von Rutkowski, P, Bylina, E, Wozniak, A, Nowecki, Z.I, Osuch, C, Matlok, M, Świtaj, T, Michej, W, Wroński, M, Głuszek, S, Kroc, J, Nasierowska-Guttmejer, A, Joensuu, H

Volltext

Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience von Kunkiel, M, Maczkiewicz, M, Jagiełło-Gruszfeld, A, Nowecki, Z

Volltext

The role of SWI/SNF chromatin remodelling complex ATPase subunit - BRM in TNBC von Jancewicz, I., Rusetska, N., Armatowska, A., Stachowiak, M., Pogoda, K., Niwińska, A., Olszewski, W., Nowecki, Z.I., Sarnowski, T.J., Sarnowska, E., Siedlecki, J.A.

Volltext

HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch von Dubianski, R., Sarnowska, E., Leszczynski, M., Kubala, S., Olszewski, W., Rusetska, N., Jagiello-Gruszfeld, A.I., Konopinski, R., Sarnowski, T.J., Siedlecki, J.A., Nowecki, Z.I.

Volltext

Subcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis von Kümmel, S., Tondini, C.A., Abraham, J., Nowecki, Z.I., Itrych, B., Hitre, E., Karaszewska, B., Juarez, A., Morales-Vásquez, F., Pérez García, J.M., Cardona-Huerta, S., Heinzmann, D., He, J., Duc, A.N., Crepelle-Fléchais, A., Martín, M.

Volltext

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperati... von Nowecki, Z.I., Rutkowski, P., Kulik, J., Siedlecki, J.A., Ruka, W.

Volltext

Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the p... von Rugo, H.S., Oliveira, M., Howell, S.J., Dalenc, F., Cortes, J., Gomez, H.L., Hu, X., Jhaveri, K.L., Krivorotko, P., Loibl, S., Morales Murillo, S., Nowecki, Z., Okera, M., Park, Y.H., Sohn, J., Toi, M., Iwata, H., Yousef, S., Zhukova, L., Logan, J., Twomey, K., Khatun, M., D’Cruz, C.M., Turner, N.C.

Volltext

The analysis of the outcomes and factors related to iliac–obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biops... von Zdzienicki, M, Rutkowski, P, Nowecki, Z.I, van Akkooi, A.C.J, Michej, W, Dziewirski, W, Świtaj, T, Pieńkowski, A, Sałamacha, M, Bylina, E, Eggermont, A.M.M

Volltext

Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection von Rutkowski, P, Dębiec-Rychter, M, Nowecki, ZI, Michej, W, Symonides, M, Ptaszynski, K, Ruka, W

Volltext

Cetuximab and panitumumab in elderly patients with metastatic colorectal cancer von Jagiello-Gruszfeld, A.I, Kosakowska, E, Nowecki, Z

Volltext

In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection von Rutkowski, P., Nowecki, Z.I., Zurawski, Z., Dziewirski, W., Nasierowska-Guttmejer, A., Świtaj, T., Ruka, W.

Volltext

Lymph node status and survival in cutaneous malignant melanoma—sentinel lymph node biopsy impact von Rutkowski, P, Nowecki, Z.I, Nasierowska-Guttmejer, A, Ruka, W

Volltext

Retrospective study comparing tolerability of trastuzumab as adjuvant setting in two groups of early breast cancer patients: ≥ 70 years vs < 70 years von Jagiello-Gruszfeld, A.I, giermek, J, Dubianski, R, Maczkiewicz, M, Nowecki, Z

Volltext

74P Clinical value of HER3/ErbB3 serum level determination in patients with breast cancer qualified for neoadjuvant chemotherapy von Kotowicz, B., Winter, P., Fuksiewicz, M., Jagiello-Gruszfeld, A.I., Nowecki, Z., Kowalska, M.M.

Volltext

252P Evolution of breast cancer biological subtypes between pre-treatment biopsy and residual disease after neoadjuvant therapy von Pogoda, K., Czopowicz, M., Bak, A., Najmrocka, D., Halasa, P., Pawlik, H., Olszewski, W., Rosinska, M., Niwinska, A., Sarnowska, E., Balata, A., Nagadowska, M., Gorniak, A., Meluch, M., Mlodzinska, A., Wojda, M., Bilska, I., Szombara, E., Nowecki, Z.

Volltext

260P Impact of HER2-low status on clinicopathological characteristics and pathological complete response in luminal and triple-negative early breast cancer von Pogoda, K., Czopowicz, M., Bak, A., Halasa, P., Najmrocka, D., Pawlik, H., Olszewski, W., Rosinska, M., Niwinska, A., Sarnowska, E., Szombara, E., Lemanska, I., Sienkiewicz, R., Brewczynska, E., Konieczna, A., Balata, A., Majstrak-Hulewska, A., Nowecki, Z.

Volltext

Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib von Ruka, W, Rutkowski, P, Szawłowski, A, Nowecki, Z, Dębiec-Rychter, M, Grzesiakowska, U, Dziewirski, W, Siedlecki, J.A, Michej, W

Volltext

Does Z0011 trial changed our clinical practice in patients with metastases in sentinel lymph node (SNB) von Nagadowska, M.M., Mentrak, Z., Michalski, W., Piechocki, J., Nowecki, Z.

Volltext